Data Sources and Study Population
The study database was created by cross-linking several national Swedish health data registers. The unique personal identity number 10 assigned to every Swedish citizen was used as the identifier in the linkage procedure that was done at the Swedish National Board of Health and Welfare. The database was anonymized according to regulations. The personal identity number and the national registers are described in the online-only Data Supplement.
In brief, adult patients ≤50 years of age who underwent primary isolated CABG in Sweden between 1997 and 2013 were included. Patients > 50 years who underwent primary isolated CABG in Sweden during the same period were included for comparison, and the total cohort was divided into 3 age groups (≤50, 51-70, and >70 years). We excluded patients who were operated on for congenital coronary malformations. The study population and baseline characteristics were obtained from the Swedish Web System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART) register. 11 The study database included information from the National Patient Register, 12 the Swedish Renal Register, 13 the National Diabetes Register, 14 and socioeconomic data from Statistics Sweden (a government agency). Data sources are described in detail in the online-only Data Supplement, and International Classification of Diseases codes for comorbid conditions are listed in Table I in the online-only Data Supplement.
Outcomes
Date and cause of death were obtained from the national Cause of Death Register. Causes of death were categorized as cardiovascular death or noncardiovascular death. Information on rehospitalization for myocardial infarction, heart failure, stroke, or repeat revascularization (percutaneous coronary intervention or CABG) was obtained from the National Patient Register. A major adverse cardiovascular event was defined as rehospitalization for myocardial infarction, stroke, heart failure, or repeat revascularization. International Classification of Diseases codes for the outcome measures are listed in Table II in the online-only Data Supplement.
Missing Data
Missing data (renal function [16%] , left ventricular ejection fraction [52%], body mass index [15%], number of bypass grafts [8.7%] ) were handled by multiple imputation. The multiple imputation procedure and additional sensitivity analyses are described in detail in the online-only Data Supplement. A complete-case analysis showed similar results as the main analysis of the imputed data set.
Statistical Methods
Patient characteristics were described by using frequencies and percentages for categorical variables, and means and standard deviations for continuous variables. The primary outcome measure was death from any cause. Patients contributed person-time in days from the date of surgery until the date of death from any cause or the end of follow-up (March 24, 2014). Secondary outcome measures included all-cause death, and a combination of rehospitalization for myocardial infarction, heart failure, stroke, or repeat revascularization. Information regarding cause of death and rehospitalization was available until December 31, 2012; therefore, the follow-up period for the secondary outcome measures ended on December 31, 2012. As a result, patients who underwent surgery during 2013 (n=90) were excluded from the secondary outcome analyses. The Kaplan-Meier method was used to calculate cumulative survival, and the log-rank test was used to compare differences between groups. Cox regression was used to estimate the risk of all-cause mortality or a combination of all-cause mortality or rehospitalization for myocardial infarction, heart failure, stroke, or repeat revascularization associated with baseline or operative variables. We calculated crude and multivariable adjusted hazard ratios 
Results

Study Population and Baseline Characteristics
In total, 4086 of 76 780 (5.3%) adult patients who underwent primary isolated CABG in Sweden between January 1997 and December 2013 were ≤50 years of age. During the same period, 36 442 patients 51 to 70 years of age (47.5%) and 36 252 patients > 70 years of age (47.2%) underwent primary isolated CABG in Sweden. The annual proportion of patients ≤50 years of age undergoing CABG varied between 4.4% and 6.7% ( Figure I in the online-only Data Supplement). Age distribution is presented in Figure II in the online-only Data Supplement. Baseline characteristics are shown in Table. Young patients were more likely to have a high body mass index, end-stage renal disease, type 1 diabetes mellitus, and to be born in a non-Nordic country than older patients. Moreover, they were less likely to have type 2 diabetes mellitus, hypertension, peripheral vascular disease, chronic obstructive pulmonary disease, heart failure, stroke, and atrial fibrillation than older patients (Table III in 
Follow-Up and Mortality
The total follow-up time of patients ≤50 years of age was 41 162 patient-years (mean, 10.1 years; standard deviation, 4.7; median, 10.9 years; quartile 1, 6.4 and quartile 3, 14.1). Figure 1 ). Survival was strongly related to age at surgery with higher mortality among older patient groups. The association between baseline characteristics and mortality is shown in Figure 2 , Figure III in the online-only Data Supplement, and Figure  IV in the online-only Data Supplement). Impaired renal function, type 1 diabetes mellitus, hypertension, peripheral vascular disease, reduced left ventricular ejection fraction, non-Nordic birth region, and marital status were significantly and independently associated with the combined outcome ( Figure 5 ). There was no difference in the composite outcome between patients older or younger than 40 years of age. Previous percutaneous coronary intervention, previous myocardial infarction, and internal mammary artery grafting were significantly associated with a lower risk of the combined outcome.
Discussion
Our results demonstrated that young adults who underwent CABG had lower long-term mortality and incidence of adverse cardiovascular events than older patients. Factors associated with an elevated risk of adverse outcome in the young patients included type 1 diabetes mellitus, low glomerular filtration rate, hypertension, peripheral vascular disease, chronic obstructive pulmonary disease, previous stroke, low left ventricular ejection fraction, alcohol dependency, marital status, and birth region.
Previous studies of CAD in young adults [5] [6] [7] [8] [9] 16 ,17 have mostly been single-center analyses, and only a few have included patients undergoing revascularization. 6, 8, 9, 16, 17 Classic cardiovascular risk factors such as hypertension, hyperlipidemia, obesity, and smoking have been found to be highly prevalent among young CAD patients. 13 In the current study, one-fifth of the patients had diabetes mellitus, which is in line with previous studies of young CAD patients undergoing revascularization. 8, 9, 16, 17 However, our results showed that young patients had a higher prevalence of type 1 diabetes mellitus but a lower prevalence of type 2 diabetes mellitus than older patients. Among patients with diabetes mellitus, 39% had type 1 diabetes mellitus (8% of the total young cohort). The prevalence of type 1 diabetes mellitus in young patients with CAD and patients undergoing CABG has rarely been studied. In a study of patients undergoing CABG, 6% of the diabetic patients had type 1 diabetes mellitus (1% of the total CABG population). 18 The prevalence of type 1 diabetes mellitus among young CAD patients undergoing CABG in the present study is notably high and has not been reported previously.
Long-term mortality among young adults in our study was comparable to mortality rates reported in previous studies of young patients undergoing CABG. 9, 16 Long-term mortality was considerably lower in comparison with elderly patients. These results contradict previous hypotheses that CAD in young patients carries a poor long-term prognosis 7 and stress the strong correlation of poor survival in elderly patients.
Fifteen years after surgery, the combined outcome of allcause mortality, repeat revascularization, or rehospitalization for myocardial infarction, heart failure, or stroke was documented in more than half of the patients. Repeat revascularization and rehospitalization for myocardial infarction were the most common events, whereas death and rehospitalization for heart failure or stroke affected a smaller proportion of patients. Similarly to mortality, the cumulative incidence of the combined outcome among young CAD patients was lower than in elderly patients.
The risk factors that significantly increased the risk of death and the combined outcome in the current study were similar to risk factors for older patients who underwent CABG 19, 20 and included type 1 diabetes mellitus, reduced glomerular filtration rate, reduced left ventricular ejection fraction, peripheral vascular disease, alcohol dependency, and marital status. Additional risk factors associated with only death were chronic obstructive pulmonary disease and previous stroke, and additional risk factors associated with only the combined outcome were hypertension and birth region.
Notably, type 1 diabetes mellitus, but not type 2, was significantly associated with worse outcomes in young patients. As previously noted, the prevalence of type 1 diabetes mellitus has not previously been thoroughly investigated in either young CAD patients or in patients undergoing CABG. The association between type 1 diabetes mellitus and long-term adverse outcome has not been assessed previously in young patients with CAD. Apart from that type 1 diabetes mellitus was highly prevalent in young patients who underwent CABG, our findings also demonstrated that type 1 diabetes mellitus was an important risk factor for death and major adverse cardiovascular events in these patients.
Previous studies of long-term prognosis after CABG in patients with diabetes mellitus have classified patients based on insulin dependency. 21 It has previously been shown that survival after CABG is adversely affected in patients requiring insulin treatment and that noninsulin-dependent diabetes mellitus is not an independent factor associated with late mortality after CABG. 21 Since we included noninsulindependent patients with type 2 diabetes mellitus in the type 2 diabetes mellitus cohort this may have led to better survival in this patient cohort than in the type 1 diabetes mellitus cohort.
A preoperative low glomerular filtration rate was a strong factor associated with death and the combination of death or adverse cardiovascular events. Previous studies have shown that already mild preoperative renal dysfunction is associated with long-term mortality after CABG, and that moderate and severe renal dysfunction is associated with increasingly worse long-term prognosis after CABG. 22, 23 It has further been demonstrated that severe renal dysfunction is associated with an increased risk of long-term cardiovascular events and death in patients undergoing CABG for acute coronary syndromes. 24 The relative risks for death or the combination of death or major cardiovascular events among young CAD patients undergoing CABG in the present study were comparable to those in previous studies.
23,24
Our results demonstrated that previous findings of preoperative renal dysfunction as a strong factor associated with death and cardiovascular events after CABG can also be applied to young patients.
Low left ventricular ejection fraction was significantly associated with an increased risk of late mortality and cardiovascular events in the current study. An association between left ventricular dysfunction and worse long-term prognosis after CABG has been demonstrated previously.
25,26 The relative risk for late death among young CAD patients who underwent CABG in the present study was comparable to previous studies in older patients. 25 The results of our study confirmed that left ventricular dysfunction was a strong factor associated with death also among young patients who underwent CABG.
Very few young patients received bilateral internal mammary artery grafting. Previous studies have shown survival and repeat revascularization benefits of bilateral internal mammary artery grafting. 27 It has been shown that, for younger patients, the relative survival benefit of bilateral internal mammary artery grafting is smaller initially than in elderly patients because of low early mortality in young patients regardless of grafting strategy. However, this survival benefit increases over time and continues to increase 20 years after CABG. 28 Although the mean follow-up of 10.1 years in the present study was long in comparison with previous studies, the benefits of bilateral internal mammary artery grafting in this age cohort appear to occur after this time point. 28 The strengths of our study included the large study population and the complete and accurate follow-up and survival ascertainment due to the high-quality national Swedish registers. Furthermore, the mean follow-up time of >10 years is very long for a study describing young adults with CAD.
There are several important limitations of the study that need to be addressed. First, the national registers used did not provide information regarding the extent of CAD, neither at the time of the primary operation nor at the possible repeat revascularization procedure. This prevents us from drawing any detailed conclusions about CAD progress among young patients. In some subgroups (eg, patients with impaired renal function), the number of patients and number of events were low, and the results in these subgroups should therefore be interpreted with caution. There was a high percentage of missing data for the preoperative variables of body mass index, left ventricular ejection fraction, and estimated glomerular filtration rate. To retain statistical power and reduce the selection bias that may occur when deleting observations with missing covariates, multiple imputation was used to handle missing data. 29 In conclusion, patients ≤50 years of age who underwent CABG had lower risks of adverse outcomes in comparison with older patients. Young adults had a higher prevalence of type 1 diabetes mellitus but a lower prevalence of type 2 diabetes mellitus than elderly patients. Factors associated with an elevated long-term risk of death or adverse outcome among young patients were similar to well-known risk factors for elderly patients. 
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CLINICAL PERSPECTIvE
Previous studies have shown that young patients with coronary artery disease (CAD) have a high prevalence of classic cardiovascular risk factors, and it has been hypothesized that CAD in young patients carries a poor long-term prognosis. However, there are limited data regarding long-term outcomes. Young adults with symptomatic CAD who require coronary artery bypass grafting (CABG) compose a specific subset of young patients with advanced CAD. We analyzed long-term survival, major adverse cardiovascular events, and factors associated with elevated risk in all adults ≤50 years of age that underwent CABG in Sweden during a 17-year period. Young adults had lower long-term mortality and incidence of adverse cardiovascular events than older patients after CABG. The factors associated with an elevated long-term risk of death or adverse outcome were similar to well-known risk factors for older age groups following CABG. Thus, in a large nationwide cohort, we found that long-term survival and freedom from major cardiovascular events after CABG was better in young adults than in older patients. Our results emphasize a favorable long-term prognosis regarding survival and freedom from major cardiovascular events after surgical revascularization in young adults with CAD, contradict the assumption of a poor prognosis in these patients, and stress the strong correlation of poor survival to older age. survival .................................................................................................................................... 5  Flexible parametric modeling of cause-specific hazards .............................................................. 5  Missing data .............................................................................................................................................. 
Supplemental Methods/Results
Swedish national registers
Personal identity number
Sweden has a universal and publicly financed health insurance coverage that guarantees equal access to health services, regardless of employment status, socio-economic status or regional residency. From 1947 and onwards, every individual who has resided in Sweden on a permanent basis has been assigned a personal identity number (PIN). 1 The Swedish PIN is the unique identifier in all national registers.
National Patient Register
The Swedish National Patient Register is maintained by a government agency, the Swedish National Board of Health and Welfare, and has complete nationwide coverage of patient treatment facilities since 1987. Diagnostic information is coded using the International Classification of Diseases (ICD) codes. The standard procedure dictates that diagnosis will be given by a consultant (equivalent of an attending) physician at the time of discharge from hospital. The diagnostic assessment is then forwarded on a computer medium to the National Patient Register. These routines are standardized across Sweden. The validity of many diagnoses has been evaluated in the Swedish National Patient Register and was found to be 95% for a primary diagnosis of heart failure; the positive predictive value was 98.6% for stroke and 98% to 100% for myocardial infarction. 2
SWEDEHEART
The Swedish Web system for Enhancement and Development of Evidence-based care in Heart disease Evaluated According to Recommended Therapies (SWEDEHEART) register includes all patients who underwent coronary angiography, percutaneous coronary intervention, or cardiac surgery or were cared for at any cardiac intensive care unit in Sweden since 1992. 3 Agreement between information in the register and the medical records was reported to be between 93% and 97%.
Cause of Death Register
The cause of death Register includes information regarding date of death and specific causes of death obtained from death certificates since 1961. The register is updated yearly and includes all deaths of persons registered in Sweden at the time of death (deaths occurring outside Sweden are therefore also recorded). Since 1997, the international version of ICD-10 is used for classification of the causes of death.
Swedish National Diabetes Register
The Swedish National Diabetes Register (NDR) was initiated in 1996 as a tool for local systematic quality assurance in diabetes care. Annual reporting to the NDR is carried out by physicians and nurses via the Internet or via clinical records databases, including information collected during patient visits at hospital outpatient clinics and primary healthcare centers nationwide. Today, 100% of hospital outpatient clinics and 95% of primary healthcare centers participate. In Sweden, almost all patients with type 1 diabetes receive their treatment at hospital outpatient clinics, with an estimated 90% of adult patients with type 1 diabetes reporting to the NDR in 2011. Demographic data, diabetes duration, and treatment modalities, as well as various risk factors and diabetes complications, are recorded. 4 The coverage of patients with type 2 diabetes mellitus is currently estimated to be 80 to 90%. 5 In the NDR, the epidemiological definition of type 1 diabetes was onset of diabetes before the age of 30 years and treatment with insulin only. Type 2 diabetes was defined as diabetes treated with diet or oral hypoglycemic agents alone, or age 40 years or older at onset and treated with insulin alone or in combination with oral hypoglycemic agents.
Swedish Renal Registry
The Swedish Renal Registry is a national health data registry for patients on maintenance renal replacement therapy. 6 Every patient with chronic renal insufficiency starting dialysis treatment or receiving a kidney transplant should be reported to the register, and all dialysis and transplant units in Sweden report to the register. Reporting of patients is virtually 100%.
Unadjusted survival
Supplemental Table 4 and Figure 3 shows the unadjusted survival analysis in patients 50 years or younger stratified by factors which have previously been shown to be associated with poor prognosis in overall CABG populations. Left ventricular function (LVEF) < 30% was associated with poor early and long-term survival and LVEF 30-50% with poor long-term survival. Estimated glomerular function < 60 was associated with poor early and long-term survival. Patients with diabetes mellitus had poor survival compared with patients without diabetes mellitus. Patients with type 1 diabetes mellitus had poorer survival than patient with type 2 diabetes mellitus. Chronic obstructive pulmonary disease and peripheral vascular disease was associated with poor long-term survival. There were no survival differences between patients undergoing CABG with or without cardiopulmonary bypass or patients with 1 or multiple arterial grafts. There was no difference in survival between patients older or younger than 40 years of age.
Flexible parametric modeling of cause-specific hazards
We used the Stata command stpm2 7 to do flexible parametric modeling of cause-specific hazards 8 to estimate cumulative incidence functions so that we could graphically show the proportion of patients who developed myocardial infarction, heart failure, stroke, or repeat revascularization, respectively, thereby accounting for the competing risk of death, that is, the possibility that death may occur before the outcome of interest.
Missing data
Some data regarding baseline characteristics were missing in the study database. It has been shown that results from analysis of only cases with complete data can be biased, and it always leads to exclusion of a proportion of the study sample which causes loss of precision and statistical power. Multiple imputation 9-11 is a generally accepted and recommended computer intensive statistical procedure that has several advantages over e.g. single imputation of the mean of the observed values or using a missing category indicator. Specifically, we used multiple imputation by chained equations (MICE) which is a flexible and efficient technique for handling missing data even in large datasets. 12 The MICE procedure consists of a series of regression models (chained equations) where each variable with missing data is modeled conditional upon the other variables in the data. This means that each variable can be modeled according to its own distribution (continuous, binary, unordered categorical, and ordered categorical). Binary variables are often modeled using logistic regression and continuous variables can e.g. be modeled using linear regression.
The imputation models included 33 variables, including the event indicator and the NelsonAalen estimator of the cumulative baseline hazard, 13 under the assumption that the missing values were missing at random. Twenty-five data sets were imputed, and estimates from these data sets were combined according to Rubin's rules.
Left ventricular ejection fraction
Data were missing for 52% of the study population regarding LVEF. We performed additional analyses comparing patients with and without information regarding LVEF. Details regarding baseline characteristics are shown in Supplemental Table 5 . In Supplemental Figure 5 , survival was compared in patients with or without missing information regarding LVEF.
Factors that are known to be closely related to prognosis, such as LVEF, renal function, type 1 diabetes mellitus, or prior stroke, were similar between patients with or without missing information regarding LVEF.
Chronic obstructive pulmonary disease, peripheral vascular disease, alcohol dependency, and marital status were not similar between patients with or without missing information regarding LVEF (chronic obstructive pulmonary disease 0.9% vs. 3.8%; peripheral vascular disease 1.5% vs. 5.3%; alcohol dependency 1.7% vs. 3.2%; married 54.6% vs. 45.8%).
Survival at 1, 5, and 10 years was similar between patients with or without missing information regarding LVEF (Supplemental Figure 5 ).
In summary, we found no evidence supporting a substantial difference between patients with or without missing LVEF information regarding baseline characteristics or survival. Therefore, the assumption that missing data regarding LVEF was "missing at random" or "missing completely at random" was plausible, and we proceeded with a multiple imputation strategy to handle missing data.
Renal function
Data were missing for 16% of the study population regarding preoperative renal function. We performed additional analyses comparing patients with and without information regarding preoperative renal function. Details regarding baseline characteristics are shown in Supplemental Table 6 . In Supplemental Figure 6 , survival was compared in patients with or without missing information regarding regarding renal function.
Factors which were shown to be closely related to prognosis such as LVEF, renal function, type 1 diabetes mellitus, prior stroke, chronic obstructive pulmonary disease, peripheral vascular disease, alcohol dependency, and marital status were similar between patients with or without missing information regarding renal function.
Survival at 1, 5, and 10 years was similar between patients with or without missing information regarding renal function (Supplemental Figure 6 ).
In summary, we found no evidence supporting a substantial difference between patients with or without missing renal function information regarding baseline characteristics or survival. Therefore, the assumption that missing data regarding renal function was "missing at random" or "missing completely at random" was plausible, and we proceeded with a multiple imputation strategy to handle missing data.
Body mass index
Data were missing for 15% of the study population regarding body mass index.
We performed additional analyses comparing patients with and without information regarding body mass index. Details regarding baseline characteristics are shown in Supplemental Table 7 . Survival was worse in patients with missing information regarding regarding body mass index (Supplemental Figure 7; p=0.001).
Factors which were shown to be closely related to prognosis such as LVEF, renal function, type 1 diabetes mellitus, prior stroke, chronic obstructive pulmonary disease, peripheral vascular disease, alcohol dependency, and marital status were similar between patients with or without missing information regarding body mass index.
In summary, we found no evidence supporting a substantial difference between patients with or without missing body mass index information regarding baseline characteristics. There was a small but statistically significant difference regarding long-term survival. Because the survival difference was small and because baseline characteristics were similar, we found it reasonable to perform multiple imputation also for body mass index. An additional complete-case analysis provided identical results.
Other variables
Data were missing for 8.7% of the study population regarding number of bypass grafts, and we used multiple imputation to handle missing data. A very small amount of missing data was present for the variables educational level (n=49), and birth region (n= 3). Missing data for these variables was imputed by replacing the missing value with the most common category. Data are n (%) unless otherwise noted. SD = standard deviation, CABG = coronary artery bypass grafting, eGFR = estimated glomerular filtration rate, PCI = percutaneous coronary intervention, SD = standard deviation. Data are n (%) unless otherwise noted. SD = standard deviation, CABG = coronary artery bypass grafting, eGFR = estimated glomerular filtration rate, PCI = percutaneous coronary intervention, SD = standard deviation.
Supplemental
Supplemental Table 7 . Baseline characteristics in patients with complete information regarding body mass index compared to patients with missing data. 
Supplemental Figures
Supplemental Figure 1 The graph displays the number of patients who underwent primary isolated CABG in Sweden each year in three age categories. There was a continuous decline in the number of procedures performed from 2003 and onwards, but the proportion of patients aged 50 years or younger each year was similar during the study period.
